Category: Biotech

• Dutch-based ExCulture secures funding from Dutch Industrial Biotech Seed Fund and Medtech TTT to produce animal-free alternative to life-saving blood thinner
• Funding round follows previous investments from UNIIQ, Delft Enterprises, and Libertatis Ergo Holding in 2023
• ExCulture, founded by Aisling Foley and Ilaria Poledri, focuses on developing a novel fermentation bioprocess for biopharmaceutical production
• Goal is to create a safer, more sustainable animal-free heparin substitute to address global shortages and contamination risks
• Capricorn Industrial Biotech Fund and MedTech consortium support ExCulture’s mission for responsible and reliable production of essential biomedical compounds

Dutch-based ExCulture Secures Funding to Produce Animal-Free Alternative to Life-Saving Blood Thinner

Leiden-based ExCulture, a biotechnology startup, has recently made headlines by securing funding for the development of an animal-free alternative to the widely used blood thinner, heparin. Read more

• London bio-tech company Tenomix Inc. secures $500,000 funding for colorectal cancer detection technology
• Ontario’s Life Sciences Innovation Fund supports Tenomix’s robotics and AI approach to improving cancer tissue processing
• Weather warnings in parts of Ontario, Quebec, and Atlantic Canada for heavy rainfall from Hurricane Beryl remnants
• Prime Minister Justin Trudeau faces criticism over NATO defence spending pledge in Washington, D.C.
• Various news updates including artist Alex Janvier’s passing, tragic accidents, police investigations, and regional developments

London Bio-Tech Company Secures Funding for Colorectal Cancer Detection

In a significant development in the healthcare technology sector, a London-based bio-tech company, Tenomix Inc., Read more

• Wisconsin Biohealth Tech Hub to receive nearly $50M in federal grant funding
• U.S. Sen. Tammy Baldwin announces the $49 million federal grant funding for the tech hub
• The hub aims to make Wisconsin a global leader in personalized medicine
• State funding, industry commitments, and Microsoft’s data center campus support the tech hub
• Projects include the Wisconsin Health Data Hub and workforce development initiatives

Wisconsin Biohealth Funding: A Game-Changer for the State’s Tech Hub

The Wisconsin Biohealth Tech Hub is set to receive a substantial boost with nearly $50 million in federal grant funding, marking a significant milestone for the state’s biohealth sector. Read more

• Ability Biologics closes extended $18m seed funding round
• Company establishing laboratories in Montreal
• Utilizes generative AI-based platform Abileap for selective antibody therapeutics
• AI platform based on large antibody-antigen interaction database
• Seed funding round led by Amplitude Ventures, with participation from Charles River Labs and Theorodus

Ability Biologics Secures $18m Seed Funding Extension

Ability Biologics, a promising biotech company focused on cancer therapeutics, has recently closed an extended seed funding round, raising a total of $18 million. Read more

• ExpressionEdits secures $13 million in funding for protein expression optimization through AI and patented intronization technology
• Founded in 2021 by Dr. Kärt Tomberg, Professor Allan Bradley, and Dr. Liliana Antunes, based on University of Cambridge research
• Funding to accelerate candidate selection for preclinical research and develop a pipeline of protein-based medicines, focusing on recombinant proteins
• Company’s AI platform combines biological data with machine learning to enhance gene design and protein production
• ExpressionEdits aims to revolutionize genetic medicine by improving protein expression and creating novel genetic medicines, supported by investors like Octopus Ventures and Red Alpine.

• LabGenius secures £35M Series B funding for therapeutic antibody discovery
• LabGenius uses EVA™, a smart robotic platform, for antibody discovery
• Addressing on-target, off-tumour toxicity in therapeutic antibodies
• LabGenius utilizes Multi-Objective Bayesian Optimisation for antibody co-optimization
• Funding led by M Ventures, with new investors Octopus Ventures and LG Corp

LabGenius Secures £35M Series B Funding for Therapeutic Antibody Discovery

LabGenius, a cutting-edge drug discovery company specializing in the use of machine learning for the identification of novel therapeutic antibodies, has successfully concluded a £35 million Series B financing round. Read more

• Brixton Biosciences secures $33M in Series B funding to advance novel technology for pain treatment
• Neural Ice™ technology shows promising results in first-in-man studies
• Capital to be used for pivotal clinical studies in chronic and acute pain indications
• Company aims to expand Neural Ice™ platform to multiple pain indications with long-lasting effects
• Appointment of Dr. Michael Fishman as Chief Medical Officer and Reggie Groves to Board of Directors

Revolutionizing Pain Treatment with Brixton Biosciences’ Neural Ice™ Technology

Pain management is a critical aspect of healthcare, with millions of individuals suffering from chronic and acute pain conditions worldwide. Read more

• NIIMBL announced funding for projects in bioprocess tech and training innovation, including intensified viral vector production and creation of “surrogate” antibody drug conjugates.
• ChromaTan and Batavia Biosciences are collaborating to integrate a novel downstream technology for adeno-associated viral vector production, aiming to reduce costs and increase yields.
• Enquyst Technologies, Lonza, MilliporeSigma, and University of Massachusetts Lowell are developing isoelectric point purification for continuous monoclonal antibody production.

• Hudson River Biotechnology, an agricultural biotech company based in Wageningen, Netherlands, secures funding from Oost NL and Eurogenetic.
• The investment will support the company in scaling up commercially and advancing its technology for new products and services.
• Led by CEO Ferdinand Los, the company uses CRISPR technology to develop new crops with enhanced properties like higher yield and improved nutritional content.

• CryoLogyx completes £500k seed funding round led by private UK business angels and the Wider Oxford Technology Angel Network
• Funding to support commercialization of cryopreserved cell technology, scale up production of assay-ready cells, and expand reach in UK and Europe
• Company spun out from University of Warwick in 2020 by CEO Dr. Tom Congdon and CSO Professor Matt Gibson
• Proprietary macromolecule cryoprotectant technology, Cryoshield, reduces post-thaw damage and saves researchers time
• Funding will allow for team expansion, scale production of cell-based assays, and accelerate development of new products and services.

• Biotech spinout Wobble Genomics raises £8.5m to commercialize RNA sequencing technology
• Funding round led by Mercia Ventures and BGF, with support from IQ Capital, EOS Advisors, and Old College Capital
• Founded in 2021 by Dr. Richard Kuo, Wobble Genomics specializes in long-read RNA sequencing
• Technology enables detection of ‘full length’ RNA, offering applications in drug development, research, agriculture, and ecology
• Company operating in stealth mode, plans to double team size in two years; total funding raised exceeds £10.5m

Biotech Spinout Raises £8.5m to Commercialise its Technology

Wobble Genomics, a promising biotech spinout originating from the University of Edinburgh, has recently secured a substantial funding round of £8.5m. Read more